Arvinas Holding Company recently held its earnings call, revealing a balanced sentiment among stakeholders. The company showcased strong clinical progress and significant collaborations, notably with ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

How could Trump's demands that drugmakers lower U.S. prices or face penalties impact pharma and biotech stocks? Seeking Alpha ...

S&P500 holds flat as traders eye Fed’s rate decision, strong GDP data, and Big Tech earnings. Market sentiment hinges on ...